Home >> Medical Devices >> Food & Beverage >>

USA Molecular Imaging Market Report 2019

Published: Aug-2019 | Format: PDF | XYZResearch | Number of pages: 112 | Code: MRS - 605852

Geographically, this report split USA into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Molecular Imaging for these regions, from 2012 to 2023 (forecast), including
    Northeast
    Midwest
    South
    West

USA Molecular Imaging market competition by top manufacturers/players, with Molecular Imaging sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Cardiarc
    Digirad
    Gamma Medica
    GE
    Gvi Medical Devices
    Hitachi
    Mediso
    CMR Naviscan
    Neurologica
    Neusoft
    BC Technical
    Philips
    Positron
    Siemens
    Biosensors International
    Toshiba
    Trivitron Healthcare
    Molecular Devices

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
    PET
    PET-CT
    PET-MR
    SPECT
    MR Spectroscopy
    Molecular Ultrasound Imaging

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Molecular Imaging for each application, including
    Cardiology
    Oncology
    Gastrointestinal Disorders
    Neurology Disorders
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

1 Report Overview
    1.1 Definition and Specification
    1.2 Report Overview
        1.2.1 Manufacturers Overview
        1.2.2 Regions Overview
        1.2.3 Type Overview
        1.2.4 Application Overview
    1.3 Industrial Chain
        1.3.1 Molecular Imaging Overall Industrial Chain
        1.3.2 Upstream
        1.3.3 Downstream
    1.4 Industry Situation
        1.4.1 Industrial Policy
        1.4.2 Product Preference
        1.4.3 Economic/Political Environment
    1.5 SWOT Analysis
2 Market Analysis by Types
    2.1 Overall Market Performance(Volume)
             2.1.1 PET Market Performance (Volume)
             2.1.2 PET-CT Market Performance (Volume)
             2.1.3 PET-MR Market Performance (Volume)
             2.1.4 SPECT Market Performance (Volume)
             2.1.5 MR Spectroscopy Market Performance (Volume)
             2.1.6 Molecular Ultrasound Imaging Market Performance (Volume)
    2.2 Overall Market Performance(Value)
             2.2.1 PET Market Performance (Value)
             2.2.2 PET-CT Market Performance (Value)
             2.2.3 PET-MR Market Performance (Value)
             2.2.4 SPECT Market Performance (Value)
             2.2.5 MR Spectroscopy Market Performance (Value)
             2.2.6 Molecular Ultrasound Imaging Market Performance (Value)
3 Market Assessment by Application
    3.1 Overall Market Performance (Volume)
             3.1.1 Cardiology Market Performance (Volume)
             3.1.2 Oncology Market Performance (Volume)
             3.1.3 Gastrointestinal Disorders Market Performance (Volume)
             3.1.4 Neurology Disorders Market Performance (Volume)
             3.1.5 Others Market Performance (Volume)
4 Manufacturers Profiles/Analysis
    4.1 Cardiarc
        4.1.1 Cardiarc Profiles
        4.1.2 Cardiarc Product Information
        4.1.3 Cardiarc Molecular Imaging Business Performance
        4.1.4 Cardiarc Molecular Imaging Business Development and Market Status
    4.2 Digirad
        4.2.1 Digirad Profiles
        4.2.2 Digirad Product Information
        4.2.3 Digirad Molecular Imaging Business Performance
        4.2.4 Digirad Molecular Imaging Business Development and Market Status
    4.3 Gamma Medica
        4.3.1 Gamma Medica Profiles
        4.3.2 Gamma Medica Product Information
        4.3.3 Gamma Medica Molecular Imaging Business Performance
        4.3.4 Gamma Medica Molecular Imaging Business Development and Market Status
    4.4 GE
        4.4.1 GE Profiles
        4.4.2 GE Product Information
        4.4.3 GE Molecular Imaging Business Performance
        4.4.4 GE Molecular Imaging Business Development and Market Status
    4.5 Gvi Medical Devices
        4.5.1 Gvi Medical Devices Profiles
        4.5.2 Gvi Medical Devices Product Information
        4.5.3 Gvi Medical Devices Molecular Imaging Business Performance
        4.5.4 Gvi Medical Devices Molecular Imaging Business Development and Market Status
    4.6 Hitachi
        4.6.1 Hitachi Profiles
        4.6.2 Hitachi Product Information
        4.6.3 Hitachi Molecular Imaging Business Performance
        4.6.4 Hitachi Molecular Imaging Business Development and Market Status
    4.7 Mediso
        4.7.1 Mediso Profiles
        4.7.2 Mediso Product Information
        4.7.3 Mediso Molecular Imaging Business Performance
        4.7.4 Mediso Molecular Imaging Business Development and Market Status
    4.8 CMR Naviscan
        4.8.1 CMR Naviscan Profiles
        4.8.2 CMR Naviscan Product Information
        4.8.3 CMR Naviscan Molecular Imaging Business Performance
        4.8.4 CMR Naviscan Molecular Imaging Business Development and Market Status
    4.9 Neurologica
        4.9.1 Neurologica Profiles
        4.9.2 Neurologica Product Information
        4.9.3 Neurologica Molecular Imaging Business Performance
        4.9.4 Neurologica Molecular Imaging Business Development and Market Status
    4.10 Neusoft
        4.10.1 Neusoft Profiles
        4.10.2 Neusoft Product Information
        4.10.3 Neusoft Molecular Imaging Business Performance
        4.10.4 Neusoft Molecular Imaging Business Development and Market Status
    4.11 BC Technical
    4.12 Philips
    4.13 Positron
    4.14 Siemens
    4.15 Biosensors International
    4.16 Toshiba
    4.17 Trivitron Healthcare
    4.18 Molecular Devices
5 Market Performance for Manufacturers
    5.1 USA Molecular Imaging Sales (K Units) and Market Share by Manufacturers (2014-2019)
    5.2 USA Molecular Imaging Revenue (M USD) and Market Share by Manufacturers (2014-2019)
    5.3 USA Molecular Imaging Price (USD/Unit) of Manufacturers (2014-2019)
    5.4 USA Molecular Imaging Gross Margin of Manufacturers (2014-2019)
    5.5 Market Concentration
6 Regions Market Performance for Manufacturers
    6.1 Northeast Market Performance for Manufacturers
        6.1.1 Northeast Molecular Imaging Sales (K Units) and Share of Manufacturers (2014-2019)
        6.1.2 Northeast Molecular Imaging Revenue (M USD) and Share of Manufacturers (2014-2019)
        6.1.3 Northeast Molecular Imaging Price (USD/Unit) of Manufacturers (2014-2019)
        6.1.4 Northeast Molecular Imaging Gross Margin of Manufacturers (2014-2019)
        6.1.5 Market Concentration
    6.2 Midwest Market Performance for Manufacturers
        6.2.1 Midwest Molecular Imaging Sales (K Units) and Share of Manufacturers (2014-2019)
        6.2.2 Midwest Molecular Imaging Revenue (M USD) and Share of Manufacturers (2014-2019)
        6.2.3 Midwest Molecular Imaging Price (USD/Unit) of Manufacturers (2014-2019)
        6.2.4 Midwest Molecular Imaging Gross Margin of Manufacturers (2014-2019)
        6.2.5 Market Concentration
    6.3 South Market Performance for Manufacturers
        6.3.1 South Molecular Imaging Sales (K Units) and Share of Manufacturers (2014-2019)
        6.3.2 South Molecular Imaging Revenue (M USD) and Share of Manufacturers (2014-2019)
        6.3.3 South Molecular Imaging Price (USD/Unit) of Manufacturers (2014-2019)
        6.3.4 South Molecular Imaging Gross Margin of Manufacturers (2014-2019)
        6.3.5 Market Concentration
    6.4 West Market Performance for Manufacturers
        6.4.1 West Molecular Imaging Sales (K Units) and Share of Manufacturers (2014-2019)
        6.4.2 West Molecular Imaging Revenue (M USD) and Share of Manufacturers (2014-2019)
        6.4.3 West Molecular Imaging Price (USD/Unit) of Manufacturers (2014-2019)
        6.4.4 West Molecular Imaging Gross Margin of Manufacturers (2014-2019)
        6.4.5 Market Concentration
7 USA  Molecular Imaging Market Performance (Sales Point)
    7.1 USA Molecular Imaging Sales (K Units) and Market Share by Regions (2014-2019)
    7.2 USA Molecular Imaging Revenue (M USD) and Market Share by Regions (2014-2019)
    7.3 USA Molecular Imaging Price (USD/Unit) by Regions (2014-2019)
    7.4 USA Molecular Imaging Gross Margin by Regions (2014-2019)
8 Development Trend for Regions (Sales Point)
    8.1 USA Molecular Imaging Sales and Growth, Sales Value and Growth Rate(2014-2019)
    8.2 Northeast Molecular Imaging Sales and Growth, Sales Value and Growth Rate(2014-2019)
    8.3 Midwest Molecular Imaging Sales and Growth, Sales Value and Growth Rate(2014-2019)
    8.4 South Molecular Imaging Sales and Growth, Sales Value and Growth Rate(2014-2019)
    8.5 West Molecular Imaging Sales and Growth, Sales Value and Growth Rate(2014-2019)
9 Upstream Source, Technology and Cost
    9.1 Upstream Source
    9.2 Technology
    9.3 Cost
10 Channel Analysis
    10.1 Market Channel
    10.2 Distributors
11 Consumer Analysis
    11.1 Cardiology Industry 
    11.2 Oncology Industry 
    11.3 Gastrointestinal Disorders Industry 
12 Market Forecast 2020-2025
    12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2020-2025
        12.1.1 USA Molecular Imaging Sales (K Units), Revenue (M USD) and Market Share by Regions 2020-2025
        12.1.2 USA Molecular Imaging Sales (K Units) and Growth Rate 2020-2025
        12.1.3 Northeast Molecular Imaging Sales (K Units), Revenue (M USD) and Growth Rate 2020-2025
        12.1.4 Midwest Molecular Imaging Sales (K Units), Revenue (M USD) and Growth Rate 2020-2025
        12.1.5 South Molecular Imaging Sales (K Units), Revenue (M USD) and Growth Rate 2020-2025
        12.1.6 West Molecular Imaging Sales (K Units), Revenue (M USD) and Growth Rate 2020-2025
        12.1.7  Molecular Imaging Sales (K Units), Revenue (M USD) and Growth Rate 2020-2025
        12.1.8  Molecular Imaging Sales (K Units), Revenue (M USD) and Growth Rate 2020-2025
        12.1.9  Molecular Imaging Sales (K Units), Revenue (M USD) and Growth Rate 2020-2025
        12.1.10  Molecular Imaging Sales (K Units), Revenue (M USD) and Growth Rate 2020-2025
    12.3 Sales (K Units), Revenue (M USD) by Types 2020-2025
        12.3.1 Overall Market Performance
        12.3.2 PET Sales (K Units), Revenue (M USD) and Growth Rate 2020-2025
        12.3.3 PET-CT Sales (K Units), Revenue (M USD) and Growth Rate 2020-2025
        12.3.4 PET-MR Sales (K Units), Revenue (M USD) and Growth Rate 2020-2025
        12.3.5 SPECT Sales (K Units), Revenue (M USD) and Growth Rate 2020-2025
    12.4 Sales by Application 2020-2025
        12.4.1 Overall Market Performance
        12.4.2 Cardiology Sales and and Growth Rate 2020-2025
        12.4.3 Oncology Sales and and Growth Rate 2020-2025
        12.4.4 Gastrointestinal Disorders Sales and and Growth Rate 2020-2025
        12.4.5 Neurology Disorders Sales and and Growth Rate 2020-2025
    12.5 Price (USD/Unit) and Gross Profit
        12.5.1 USA Molecular Imaging Price (USD/Unit) Trend 2020-2025
        12.5.2 USA Molecular Imaging Gross Profit Trend 2020-2025
13 Conclusion



                        
            

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields

Single User | $(USD)3450 View Pricing